Vsm Wealth Advisory, LLC Cyclacel Pharmaceuticals, Inc. Transaction History

Vsm Wealth Advisory, LLC

  • $280 Billion
  • Q4 2024

A detailed history of Vsm Wealth Advisory, LLC transactions in Cyclacel Pharmaceuticals, Inc. stock. As of the latest transaction made, Vsm Wealth Advisory, LLC holds 4,935 shares of CYCC stock, worth $1,529. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,935
Holding current value
$1,529
% of portfolio
0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025
BUY
$0.32 - $1.5 $1,579 - $7,402
4,935 New
4,935 $36 Million

About Cyclacel Pharmaceuticals, Inc.

CYCC Quotes by TradingView
  • Ticker CYCC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,539,200
  • Market Cap $3.89M
  • Description
  • Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors, as well as in combin...
More about CYCC
Track This Portfolio

Track Vsm Wealth Advisory, LLC Portfolio

Follow Vsm Wealth Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vsm Wealth Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vsm Wealth Advisory, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email